Dynamics of PBi behavior in blood serum of patients with Graves-Basedow disease and toxic nodular goiter during treatment with methimetazole
Jaruga-Dolińska, E.; Zembrzuska, Z.; Korman, E.
Endokrynologia Polska 22(6): 535-543
1971
ISSN/ISBN: 0423-104X PMID: 4110630 Document Number: 37616
Document emailed within 1 workday
Related Documents
Schicha, H.; Dietlein, M. 2002: Graves' disease nd toxic nodular goiter--radioiodine therapy NUKLEARMEDIZIN. Nuclear Medicine 41(2): 63-70Goday-Arnó, A.; García Rico, A.; Martínez-Riquelme, A.; Cano-Pérez, J.F. 1996: Graves Basedow disease following treatment with magistral formulae for obesity. Jod-Basedow phenomenon? Revista Clinica Espanola 196(8): 536-538
Gedik, O.; Ozdemir, T.; Akalin, S. 1991: Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter Israel Journal of Medical Sciences 27(7): 361-364
Titov, V.N.; Parkhimovich, R.M. 1971: Dynamics of protein-bound serum iodine during surgical treatment of diffuse toxic goiter Vestnik Khirurgii Imeni I. I. Grekova 106(2): 7-10
Cheren'ko, M.P. 1972: Development of primary diffuse toxic goiter in a patient previously subjected to surgery for euthyroid nodular goiter Klinicheskaia Khirurgiia 9: 72-73
Studer, H.; Huber, G.; Derwahl, M.; Frey, P. 1989: The transformation of Basedow's struma into nodular goiter: a reason for recurrence of hyperthyroidism Schweizerische Medizinische Wochenschrift 119(7): 203-208
Rybiński, K.; Kuzdak, K. 1984: Changes in the levels of thyrotropin and thyroid hormones in patients after strumectomy in non-toxic nodular goiter Endokrynologia Polska 35(6): 365-371
Alesov, V.Z. 1976: A comparative assessment of the efficacy of antithyroid therapy in patients with nodular and diffuse toxic goiter Problemy Endokrinologii 22(1): 12-15
Lipets, A.I.; Dozorets, I.L.; Seleznev, L.E. 1971: Dynamics of some indices of the glucocorticoid function of the adrenal cortex in patients with a severe form of diffuse toxic goiter under the effect of radioiodine treatment Sovetskaia Meditsina 34(9): 63-65
Cheren'ko, M.P.; Federiko, A.N.; Ignatovskiĭ, I.V.; Cheren'ko, S.M. 1988: Prevention of the recurrence of disease and hypothyroidism in the surgical treatment of patients with nodular forms of goiter Klinicheskaia Khirurgiia 1988(5): 25-27
Schreiber, V.; Tomsová, Z.; Límanová, Z.; Jůzová, Z. 1989: Increased urinary excretion of neopterin in patients with Graves-Basedow disease Casopis Lekaru Ceskych 128(28): 883-884
Grigor'eva, L.P.; Stroev, E.A.; Dubinina, I.I. 1982: Free amino acid spectrum and cathepsin activity in the blood serum of patients with diabetes mellitus combined with diffuse toxic goiter Problemy Endokrinologii 28(3): 13-16
Giedroyć, J.; Kopacz, A.; Kucharski, A.; Skokowski, J. 1975: Incidence of carcinoma in non-toxic nodular goiter Polski Przeglad Chirurgiczny 47(3): 373-377
Arteaga, E.; Campusano, C.; Michaud, P. 1993: Basedow-Graves disease development in 2 patients with primary hypothyroidism: exceptional development of the autoimmune thyroid disease Revista Medica de Chile 121(11): 1300-1304
Hanzlik, J.; Mardarowicz, G. 1976: Graves-Basedow disease and pregnancy Polski Tygodnik Lekarski 31(52): 2239-2241
Lungu, G.; Zosin, I.; Miloş, A.; Vlad, A.; Radu, M.; Popescu, D.; Toro, L.; Velea, P.; Opreanu, R.; Radu, H. 1988: Epidemiological aspects of Graves'-Basedow's disease Endocrinologie 26(2): 107-111
Fazakas, S.; Kiss, B.; Erdei, I.; Petrányi, G. 1975: Hypothyreosis after I-131 therapy of Graves-Basedow disease Orvosi Hetilap 116(43): 2523-2526
Manero Ruiz, F.J.; Playán Usón, J.; Acha Pérez, J.; Sanz París, A. 1998: Methimazole arthritis in Graves Basedow disease Anales de Medicina Interna 15(1): 47-48
Martí Cabané, J. 2003: Graves-Basedow disease, factors that influence in their relapse Anales de Medicina Interna 20(7): 388
Szczurek, Z.; Zych, F.; Zwirska-Korczala, K. 1980: Morphological picture of the thyroid gland in Graves - Basedow's disease Polski Tygodnik Lekarski 35(41): 1565-1567